
Cultured meat was presented to the world as one of the greatest promises of modern biotechnology. The concept seemed like an engineering miracle capable of producing real steaks without having to sacrifice any animals. The hype quickly attracted billions of dollars in investment and was marketed as a revolution capable of transforming the global food supply, but while the technology was grabbing headlines and generating excitement, one detail remained unknown to the general public.

Producing fetal bovine serum involves a complex process of collection, filtration, and quality control, making it one of the most expensive inputs in biotechnology; depending on its purity and application, a single liter can cost thousands of dollars, making large-scale production economically unfeasible. As this issue began to gain attention, investors, consumers, and researchers intensified the pressure to find alternatives that were entirely free of animal-derived components.

Posted Using INLEO